Oliver Sol

Technik-/Wissenschafts-/F&E-Leiter bei AC IMMUNE SA

58 Jahre

Health Technology

Consumer Services

Aktive Positionen von Oliver Sol

Unternehmen	Position	Beginn	Ende
AC IMMUNE SA	Technik-/Wissenschafts-/F&E-Leiter	-	-
AC IMMUNE SA	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
EUROBIO SCIENTIFIC	Technik-/Wissenschafts-/F&E-Leiter	-	-
EUROBIO SCIENTIFIC	General Counsel	-	-
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Technik-/Wissenschafts-/F&E-Leiter	-	-

International

Frankreich	4
Schweiz	2

Operativ

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	1
General Counsel	1

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
AC IMMUNE SA	Health Technology
EUROBIO SCIENTIFIC	Health Technology

Private Unternehmen	2
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Health Technology
Université de Paris XI Paris Sud	Consumer Services

Private Unternehmen

Health Technology

Université de Paris XI Paris Sud

Consumer Services